Exact Mass: 556.3975
Exact Mass Matches: 556.3975
Found 213 metabolites which its exact mass value is equals to given mass value 556.3975
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Hericene A
Hericene A is found in mushrooms. Hericene A is from the edible lions mane mushroom (Hericium erinaceum). From the edible lions mane mushroom (Hericium erinaceum). Hericene A is found in mushrooms.
Germanicol cinnamate
Germanicol cinnamate is found in fats and oils. Germanicol cinnamate is isolated from shea butte Isolated from shea butter. Germanicol cinnamate is found in fats and oils.
3beta,15alpha-Diacetoxylanosta-8,24-dien-26-oic acid
3beta,15alpha-Diacetoxylanosta-8,24-dien-26-oic acid is found in mushrooms. 3beta,15alpha-Diacetoxylanosta-8,24-dien-26-oic acid is a constituent of Ganoderma lucidum (reishi). Constituent of Ganoderma lucidum (reishi). 3beta,15alpha-Diacetoxylanosta-8,24-dien-26-oic acid is found in mushrooms.
Demecarium
Demecarium bromid is an indirect-acting parasympathomimetic agent that is used to treat glaucoma. It is a cholinesterase inhibitor or an anticholinesterase. Cholinesterase inhibitors prolong the effect of acetylcholine, which is released at the neuroeffector junction of parasympathetic postganglion nerves, by inactivating the cholinesterases that break it down. Demecarium inactivates both pseudocholinesterase and acetylcholinesterase. In the eye, this causes constriction of the iris sphincter muscle (causing miosis) and the ciliary muscle. The outflow of the aqueous humor is facilitated, which leads to a reduction in intraocular pressure.
DG(8:0/PGF1alpha/0:0)
DG(8:0/PGF1alpha/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/PGF1alpha/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(PGF1alpha/8:0/0:0)
DG(PGF1alpha/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(PGF1alpha/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(8:0/0:0/PGF1alpha)
DG(8:0/0:0/PGF1alpha) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(PGF1alpha/0:0/8:0)
DG(PGF1alpha/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
3beta,15alpha-Diacetoxylanosta-8,24-dien-26-oic acid
22-(3-Methyl-2-butenoyl) -(3beta,16alpha,22alpha)-12-Oleanene-3,16,22,28-tetrol|camelliagenine A, 22-beta,beta-dimethylacrylate
(2I<<,3EC)- 2,3-Bis(acetyloxy)-olean- 12-en-28-oic acid
(6S,24xi)-diacetyloxy-29-nor-3,4-seco-cycloart-4(30),25-dien-3-oic acid methyl ester
12alpha-(3-propanoyloxybutanoyloxy)-20,24-dimethyl-24-oxoscalar-16-en-25-al
12alpha-(3-acetoxypentanoyloxy)-20,24-dimethyl-24-oxoscalara-16-en-25-al
3,23-di-O-acetylhederagenin|3,23-diacetylhederagenin|3beta,23-Diacetoxy-olean-12-en-28-saeure|3beta.23-diacetoxy-oleanen-(12)-oic acid-(28)|3beta.23-Diacetoxy-oleanen-(12)-saeure-(28)|diacetyl hederagenin|hederagenin diacetate
16-Tigloyl-(3beta,16alpha,22alpha)-12-Oleanene-3,16,22,28-tetrol
22-Angeloyl-(3beta,16alpha,22alpha)-12-Oleanene-3,16,22,28-tetrol|22-O-angeloylcamelliagenin A|Olean-12-en-3beta,16alpha,22alpha,28-tetrol-22-angelat
3beta-(benzoyloxy)glutina-5(10),6-dien-27,8alpha-olide|phyllenolide B
3beta-(E)-cinnamoyloxyeupha-8,24-diene|euphol 3-O-cinnamate
Ile Ile Arg Arg
Ile Leu Arg Arg
Ile Arg Ile Arg
Ile Arg Leu Arg
Ile Arg Arg Ile
Ile Arg Arg Leu
Leu Ile Arg Arg
Leu Leu Arg Arg
Leu Arg Ile Arg
Leu Arg Leu Arg
Leu Arg Arg Ile
Leu Arg Arg Leu
Arg Ile Ile Arg
Arg Ile Leu Arg
Arg Ile Arg Ile
Arg Ile Arg Leu
Arg Leu Ile Arg
Arg Leu Leu Arg
Arg Leu Arg Ile
Arg Leu Arg Leu
Arg Arg Ile Ile
Arg Arg Ile Leu
Arg Arg Leu Ile
Arg Arg Leu Leu
Germanicol cinnamate
3b,15a-Diacetoxylanosta-8,24-dien-26-Oic acid
Hericene A
Demecarium
S - Sensory organs > S01 - Ophthalmologicals > S01E - Antiglaucoma preparations and miotics > S01EB - Parasympathomimetics D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D002800 - Cholinesterase Inhibitors C471 - Enzyme Inhibitor > C47792 - Acetylcholinesterase Inhibitor D004791 - Enzyme Inhibitors
1-[[(8R,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-1-methyl-3-[4-(4-methyl-1-piperazinyl)phenyl]urea
1-[[(8S,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-1-methyl-3-[4-(4-methyl-1-piperazinyl)phenyl]urea
1-[[(8R,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-1-methyl-3-[4-(4-methyl-1-piperazinyl)phenyl]urea
1-[[(8R,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-1-methyl-3-[4-(4-methyl-1-piperazinyl)phenyl]urea
1-[[(8R,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-1-methyl-3-[4-(4-methyl-1-piperazinyl)phenyl]urea
1-[[(8R,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-1-methyl-3-[4-(4-methyl-1-piperazinyl)phenyl]urea
1-[[(8R,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-1-methyl-3-[4-(4-methyl-1-piperazinyl)phenyl]urea
1-[[(8S,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-1-methyl-3-[4-(4-methyl-1-piperazinyl)phenyl]urea
(1R,1R,10R,12R,13S,14S,14R)-14,14-diethylspiro[8,15-diazapentacyclo[10.5.1.01,9.02,7.015,18]octadeca-2,4,6,8-tetraene-10,10-8,16-diazahexacyclo[11.5.2.11,8.02,7.016,19.012,21]henicosa-2,4,6,12(21)-tetraene]
[(E)-2-[[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]amino]-3-hydroxyoct-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
[2-[[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]amino]-3-hydroxyoctyl] 2-(trimethylazaniumyl)ethyl phosphate
(1-hydroxy-3-octanoyloxypropan-2-yl) (6Z,9Z,12Z,15Z,18Z,21Z)-tetracosa-6,9,12,15,18,21-hexaenoate
[1-hydroxy-3-[(Z)-tetradec-9-enoyl]oxypropan-2-yl] (3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoate
[2-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxy-3-hydroxypropyl] (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate
[2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxy-3-hydroxypropyl] (9Z,12Z)-hexadeca-9,12-dienoate
(1-decanoyloxy-3-hydroxypropan-2-yl) (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate
(Z)-12,13-Bis[(tert-butyldimethylsilyl)oxy]-9-octadecenoic acid methyl ester
(Z)-9,10-Bis[(tert-butyldimethylsilyl)oxy]-12-octadecenoic acid methyl ester
[1-carboxy-3-[2-[(E)-dec-4-enoyl]oxy-3-undecanoyloxypropoxy]propyl]-trimethylazanium
[(2S)-2-decanoyloxy-3-hydroxypropyl] (4E,7E,10E,13E,16E,19E)-docosa-4,7,10,13,16,19-hexaenoate
[1-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-3-hydroxypropan-2-yl] (E)-hexadec-7-enoate
[1-carboxy-3-[3-decanoyloxy-2-[(E)-undec-4-enoyl]oxypropoxy]propyl]-trimethylazanium
[1-carboxy-3-[2-decanoyloxy-3-[(E)-undec-4-enoyl]oxypropoxy]propyl]-trimethylazanium
[2-[(9E,11E,13E)-hexadeca-9,11,13-trienoyl]oxy-3-hydroxypropyl] (9E,11E,13E)-hexadeca-9,11,13-trienoate
[1-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxy-3-hydroxypropan-2-yl] (4E,7E)-hexadeca-4,7-dienoate
[(2S)-1-decanoyloxy-3-hydroxypropan-2-yl] (4E,7E,10E,13E,16E,19E)-docosa-4,7,10,13,16,19-hexaenoate
[1-carboxy-3-[3-[(E)-dec-4-enoyl]oxy-2-undecanoyloxypropoxy]propyl]-trimethylazanium
[2-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxy-3-hydroxypropyl] (4E,7E)-hexadeca-4,7-dienoate
[1-carboxy-3-[3-hexanoyloxy-2-[(Z)-pentadec-9-enoyl]oxypropoxy]propyl]-trimethylazanium
[3-[3-acetyloxy-2-[(Z)-nonadec-9-enoyl]oxypropoxy]-1-carboxypropyl]-trimethylazanium
[1-carboxy-3-[2-[(Z)-octadec-9-enoyl]oxy-3-propanoyloxypropoxy]propyl]-trimethylazanium
[1-carboxy-3-[3-heptanoyloxy-2-[(Z)-tetradec-9-enoyl]oxypropoxy]propyl]-trimethylazanium
[3-[3-butanoyloxy-2-[(Z)-heptadec-9-enoyl]oxypropoxy]-1-carboxypropyl]-trimethylazanium
[1-carboxy-3-[2-[(Z)-hexadec-9-enoyl]oxy-3-pentanoyloxypropoxy]propyl]-trimethylazanium
[1-carboxy-3-[3-octanoyloxy-2-[(Z)-tridec-9-enoyl]oxypropoxy]propyl]-trimethylazanium
2-[[3-[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoxy]-2-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[carboxy-[3-[(11Z,14Z)-henicosa-11,14-dienoyl]oxy-2-hydroxypropoxy]methoxy]ethyl-trimethylazanium
5-[(2-methoxy-5,6-dimethyl-4-oxopyran-3-yl)methyl]-1,4a-dimethyl-6-methylidene-1-(4-methylpent-3-en-1-yl)-hexahydro-2h-naphthalen-2-yl 2-hydroxy-3-methylpentanoate
(1r,3ar,5ar,5br,7ar,9s,11ar,11br,13ar,13bs)-3a,5a,5b,8,8,11a-hexamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-9-yl (2e)-3-phenylprop-2-enoate
(1r,3r,7r,9z,11r,13r,15s,16s,17r)-3,5-dihydroxy-16-isopropyl-6,10,13-trimethyl-2-methylidene-4-oxotetracyclo[9.7.0.0³,⁷.0¹³,¹⁷]octadeca-5,9-dien-15-yl 3-hydroxy-3,5-dimethylheptanoate
methyl 3-[(1s,4r,5r,8s,9s,11s,12s,13r)-11-(acetyloxy)-5-[(2r,5r)-5-(acetyloxy)-6-methylhept-6-en-2-yl]-12-ethenyl-4,8-dimethyltetracyclo[7.5.0.0¹,¹³.0⁴,⁸]tetradecan-13-yl]propanoate
(3s,4ar,6ar,6bs,8ar,12as,14ar,14bs)-4,4,6a,6b,8a,11,11,14b-octamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl (2e)-3-phenylprop-2-enoate
(3s,4ar,6ar,6bs,8ar,11r,12s,12ar,14ar,14br)-4,4,6a,6b,8a,11,12,14b-octamethyl-2,3,4a,5,6,7,8,9,10,11,12,12a,14,14a-tetradecahydro-1h-picen-3-yl (2e)-3-phenylprop-2-enoate
4,9,9,14,17,20,20-heptamethyl-23-oxo-24-oxahexacyclo[11.9.2.0¹,¹⁴.0⁴,¹³.0⁵,¹⁰.0¹⁷,²²]tetracosa-5(10),11-dien-8-yl benzoate
4,4,6a,6b,8a,11,11,14b-octamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl 3-phenylprop-2-enoate
2,19,25-trihydroxy-1,12-ursadien-28-oic acid; 19α-form,1-(2-methylpropanoyl)
{"Ingredient_id": "HBIN003535","Ingredient_name": "2,19,25-trihydroxy-1,12-ursadien-28-oic acid; 19\u03b1-form,1-(2-methylpropanoyl)","Alias": "NA","Ingredient_formula": "C34H52O6","Ingredient_Smile": "NA","Ingredient_weight": "556.77","OB_score": "NA","CAS_id": "145701-14-0","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "9035","PubChem_id": "NA","DrugBank_id": "NA"}
α-amyrin cinnamate
{"Ingredient_id": "HBIN015370","Ingredient_name": "\u03b1-amyrin cinnamate","Alias": "NA","Ingredient_formula": "C39H56O2","Ingredient_Smile": "CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)C)OC(=O)C=CC6=CC=CC=C6)C)C)C2C1C)C)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "1114","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}